Nasus Pharma Ltd (NSRX) (CIK 0002029039) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001493152-26-009621
- Form
- CORRESP
- Filer
- Nasus Pharma Ltd (NSRX) (CIK 0002029039)
- CIK
- 0002029039
- Ticker
- NSRX
- Filed
- 2026-03-11
- SIC industry
- 2834
- HQ
- Tel Aviv - Yafo, L3
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/2029039/000149315226009621/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer